
According to analytics firm IQVIA, Indian generics saved the US healthcare system $219 billion in 2022 and $1.3 trillion between…
In 2023-24, India’s medical device exports to the US stood at $714.38 million, while imports from the US to India…
IgAN is a progressive, rare kidney disease in which the immune system attacks the kidneys, often causing glomerular inflammation and…
Presently, India imposes 10 percent tariff on Pharma imports from the United States. The US doesn’t impose any tariff on…
The company said it will expand its weight-loss offerings with branded versions of Lilly’s tirzepatide.
Jefferies maintains that companies with mixed revenue streams, such as specialty pharma, biosimilars, and inhalers, may face some impact.
As a precaution, officials conducted a survey but found no new cases, including among the girl’s family members.
People who chew around 180 pieces of gum a year could be ingesting roughly 30,000 microplastics, the researchers said.
The Rapid Eye Movement (REM) stage is marked by quick movements of the eyes, increased activity in the brain and…
Dr Lal further added that children who are glued to reels for hours daily are at risk of developing early…
Norovirus Outbreak on Luxury Cruise: In addition to New York, the ship had stops in St. Maarten, St. Lucia, Grenada,…
Aimed has also sought Nadda’s “urgent intervention” and “roll back the unfair discriminatory notification”.
The company is expanding its cardiology portfolio with a new treatment for transthyretin amyloid cardiomyopathy in Europe.
The US report criticizes India’s drug price controls on medical devices like stents and knee implants, citing concerns over inflation…
Nipah virus belongs to the Paramyxovirus family. It is one of the deadliest pathogens known to infect humans.
WHO’s report on antifungal drugs highlights that, in the past decade, only four new antifungal drugs have been approved by…
GlobalData’s Emerging Market Outsourcing report reveals that this push for domestic production could lead to increased production costs and inflationary…
Drugmakers have argued that tariffs could increase the chance of drug shortages and reduce access for patients.